Continuous difference-in-differences with double/debiased machine learning

summary

The gist

Continuous difference-in-differences with double/debiased machine learning extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional…

In short

The paper extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption. It uses double/debiased machine learning to estimate the average treatment effect at any given treatment intensity, establishing their asymptotic normality and providing methods for inference.

Key concepts

Difference-in-Differences (DiD)
A statistical method used to estimate the causal effect of a policy or intervention by comparing changes in outcomes between a group that received the treatment and a control group that did not. It relies on the assumption that, without the treatment, both groups would have followed similar trends over time.
Continuous Treatment Intensity (d)
This refers to situations where the treatment is not binary (yes/no) but rather a continuous variable, such as a percentage of patients receiving a new medical procedure. The goal is to estimate how the outcome changes for every possible level of this continuous treatment intensity.
Double/Debiased Machine Learning (DML)
A powerful machine learning framework used to estimate causal parameters in high-dimensional settings. It helps reduce bias by using a combination of nuisance parameter estimation and machine learning techniques, ensuring that the final causal estimate is robust and asymptotically normal.

Terminology used across episodes

This episode discusses

The paper

Continuous difference-in-differences with double/debiased machine learning · Read on arXiv

Lucas Zheng Zhang

University of California, Los Angeles · Bates White Economic Consulting

DOI: 10.1093/ectj/utaf024

Transcript

Introduction to the show: ident: Economics. The day in economics: theory, mechanisms and the evidence beneath them.

Ruth: I'm Ruth.

Warren: And I'm Warren, here with Iris.

Ruth: We're looking at the paper: "Continuous difference-in-differences with double/debiased machine learning".

Warren: Here's the gist of the paper. Continuous difference-in-differences with double/debiased machine learning extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg2>.

Ruth: Identification Framework The paper extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg4>.

Warren: The identification results are based on a conditional parallel trends assumption, allowing researchers to account for covariates non-parametrically <ref:2408.10509#pg7>.

Ruth: The target parameter is the average treatment effect on the treated (ATT for short) at any given continuous treatment intensity d, defined as AT T(d):= E

Yt(d) − Yt(0)D = d: <ref:2408.10509#pg3>.

Paper summary: Ruth: So to recap the main thrust of this paper, they are extending difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg4>.

Warren: The core claim is that they can now identify the average treatment effect on the treated at any level of treatment intensity, AT T(d), even when you have continuous treatments <ref:2408.10509#pg3>.

Iris: They address the problem by first estimating infinite-dimensional nuisance parameters, specifically the conditional density of that continuous treatment, which they know can cause substantial bias <ref:2408.10509#pg4>.

Ruth: To counter that, they propose estimators for causal parameters using the double/debiased machine learning framework and prove their asymptotic normality <ref:2408.10509#pg4>. They introduce an approximate causal parameter AT Th using a kernel function to get around the direct application of those ML methods <ref:2408.10509#pg4>.

Warren: The motivation is clear: continuous treatments are common, and you can investigate how outcomes vary across different treatment intensities within the treated group <ref:2408.10509#pg2>.

Iris: And they use a conditional parallel trends assumption to make the identification robust, which lets them condition on covariates that influence outcome dynamics <ref:2408.10509#pg3>.

Ruth: The implication is that instead of just looking at an aggregate effect, you can look at how the effect changes as the treatment dose increases <ref:2408.10509#pg2>.

Warren: It’s a way to investigate those varying levels of exposure without having to rely on simpler models that might miss important nuances <ref:2408.10509#pg8>.

Conclusion: Ruth: So looking at "Continuous difference-in-differences with double/debiased machine learning," the authors are basically giving us a way to handle continuous treatment variables in difference-in-differences settings <ref:2408.10509#pg1>.

Warren: They’ve shown that by using double/debiased machine learning, you can get estimators for the causal parameters and prove they have asymptotic normality <ref:2408.10509#pg4>.

Iris: The real implication is that this gives researchers new tools for examining the impacts of continuous treatment variables in empirical research <ref:2408.10509#pg8>.

Ruth: It means we can move past just binary treatments and start looking at how outcomes vary across different treatment intensities with more rigor and precision #page two of that work reads: "there is growing interest in extending DiD to continuous treatments."

Warren: So, for the listener, it’s about having a new way to analyze policy or exposure effects that aren't just on or off, but are spread out across a continuum <ref:2408.10509#pg1>.

Iris: It’s about giving researchers more tools to look at these complex exposures with better identification and inference than what was previously available in this area <ref:2408.10509#pg8>.

More episodes

← Home